CONFIDENTIAL STOCK PURCHASE AGREEMENTStock Purchase Agreement • August 14th, 2001 • Sicor Inc • Pharmaceutical preparations
AGREEMENTDistribution Agreement • August 14th, 1997 • Gensia Sicor Inc • Pharmaceutical preparations • California
SICOR INC.Purchase Agreement • October 17th, 2001 • Sicor Inc • Pharmaceutical preparations • New York
EXHIBIT 10.34 LOAN AND SECURITY AGREEMENT by and between GENSIA SICOR PHARMACEUTICALS, INC.Loan and Security Agreement • March 31st, 1999 • Gensia Sicor Inc • Pharmaceutical preparations • California
LICENSE AGREEMENT -----------------License Agreement • May 15th, 1997 • Gensia Sicor Inc • Pharmaceutical preparations • England
EXHIBIT 4.1 AMENDMENT NO. 3 TO SHAREHOLDER'S AGREEMENT ------------------------------------------ AMENDMENT NO. 3 (the "Amendment"), dated as of May 19, 1997, to the Shareholder's Agreement, dated as of November 12, 1996, as amended by Amendment No. 1...Shareholder Agreement • August 14th, 1997 • Gensia Sicor Inc • Pharmaceutical preparations • New York
EXHIBIT 4.1 STOCK PURCHASE AGREEMENT ------------------------Stock Purchase Agreement • April 4th, 1997 • Gensia Inc • Pharmaceutical preparations • California
AgreementAgency Agreement • May 15th, 1997 • Gensia Sicor Inc • Pharmaceutical preparations
REGISTRATION RIGHTS AGREEMENT between GENSIA SICOR INC. and HEALTH CARE CAPITAL PARTNERS L.P. Dated as of May 19, 1997Registration Rights Agreement • August 14th, 1997 • Gensia Sicor Inc • Pharmaceutical preparations • Delaware
BETWEENSecurities Purchase Agreement • March 31st, 1999 • Gensia Sicor Inc • Pharmaceutical preparations • Delaware
AGREEMENTLicensing Agreement • May 15th, 1997 • Gensia Sicor Inc • Pharmaceutical preparations
SICOR Societa Italiana Corticosteroidi S.p.A., with corporate headquarters in Rho (Milan) Via Terrazano no. 77, tax identification number and VAT file number 06827530152, represented by the acting legal representative, Dr. Gaetano Palladino, who holds the necessary powers of attorney
BetweenShareholder Agreement • March 14th, 1997 • Gensia Inc • Pharmaceutical preparations • New York
EXHIBIT 4.2 AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT ------------------------------------------------ AMENDMENT NO. 1 (the "Amendment"), dated as of January 20, 1998, to the Registration Rights Agreement, dated as of May 19, 1997 (the...Registration Rights Agreement • January 20th, 1998 • Gensia Sicor Inc • Pharmaceutical preparations • Delaware
AGREEMENT ---------Marketing Agreement • August 14th, 1997 • Gensia Sicor Inc • Pharmaceutical preparations
EXHIBIT 10.42 AMENDMENT TO SEVERANCE AGREEMENT THIS AMENDMENT is entered into as of December 16, 1997, by and between DAVID F. HALE (the "Employee") and GENSIA SICOR INC., a Delaware corporation (the "Company"). 1. Amendment. --------- Section 7...Severance Agreement • March 31st, 1998 • Gensia Sicor Inc • Pharmaceutical preparations
By: _________________________________ Title: ______________________________Unit Purchase Agreement • January 20th, 1998 • Gensia Sicor Inc • Pharmaceutical preparations • California
WITNESSETH:Development and Supply Agreement • March 31st, 1998 • Gensia Sicor Inc • Pharmaceutical preparations • Oregon
EXHIBIT 10.57 AMENDMENT NO. 1 TO RIGHTS AGREEMENT ----------------------------------- THIS AMENDMENT NO. 1 (this "Amendment"), dated as of November 12, 1996, to the Rights Agreement, dated as of March 16, 1992 (the "Rights Agreement"), between Gensia,...Rights Agreement • March 31st, 1997 • Gensia Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10.35 CONSULTING AGREEMENT -------------------- THIS AGREEMENT (the "Agreement"), entered into as of this 27th day of January, 1998 between GREENFIELD CHEMICAL, INC., with an office at 1409 Newgate, Libertyville, Illinois 60048 ("Consultant"),...Consulting Agreement • March 31st, 1999 • Gensia Sicor Inc • Pharmaceutical preparations • California
2 1. DEFINITIONS Whenever used in this Agreement, the terms defined in this Section 1 shall have the meanings specified. 1.1 "AFFILIATE" means any corporation or other legal entity owning, directly or indirectly, fifty percent (50%) or more of the...Collaborative Research Agreement • October 22nd, 1996 • Gensia Inc • Pharmaceutical preparations • New York
SICOR Inc. 19 Hughes Irvine, CA 92618 May 31, 2001Consulting Agreement • August 14th, 2001 • Sicor Inc • Pharmaceutical preparations • Delaware
SALES AND DISTRIBUTION AGREEMENT --------------------------------Sales and Distribution Agreement • May 14th, 1999 • Gensia Sicor Inc • Pharmaceutical preparations • Illinois
EXHIBIT 10.1 ------------ [CERTAIN INFORMATION HAS BEEN OMITTED HEREIN PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT UNDER RULE 24b-2. THE REDACTED MATERIAL HAS BEEN SEPARATELY FILED WITH THE COMMISSION.] COLLABORATIVE RESEARCH AND DEVELOPMENT...Collaborative Research and Development Agreement • May 15th, 1997 • Gensia Sicor Inc • Pharmaceutical preparations • California
AMENDMENT NO. ONE TO CYCLOSPORINE AMENDED AND RESTATED SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • May 20th, 1998 • Gensia Sicor Inc • Pharmaceutical preparations
1 EXHIBIT 10.4 STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (the "Agreement") is made as of the ninth day of January, 1997 by and between GENSIA, INC., a Delaware corporation (the "Company"), and ARMEN PARTNERS OFFSHORE FUND, LTD., a Bermuda...Stock Purchase Agreement • February 24th, 1997 • Gensia Inc • Pharmaceutical preparations • California
ARTICLE 1 DEFINITIONSDevelopment, Manufacturing and Marketing Agreement • August 14th, 2000 • Sicor Inc • Pharmaceutical preparations
EXHIBIT 10.2 ------------ [CERTAIN INFORMATION HAS BEEN OMITTED HEREIN PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT UNDER RULE 24b-2. THE REDACTED MATERIAL HAS BEEN SEPARATELY FILED WITH THE COMMISSION.] SUPPLY AGREEMENT ---------------- by and...Supply Agreement • May 15th, 1997 • Gensia Sicor Inc • Pharmaceutical preparations
Exhibit 4.1 UNIT PURCHASE AGREEMENT Gensia Sicor Inc. 19 Hughes Irvine, California 92618 Ladies & Gentlemen: The undersigned purchaser (the "Purchaser") hereby confirms its agreement with you as follows: 1. This Unit Purchase Agreement (the "Purchase...Unit Purchase Agreement • August 13th, 1999 • Sicor Inc • Pharmaceutical preparations • California
AGREEMENT ---------Marketing Agreement • May 15th, 1997 • Gensia Sicor Inc • Pharmaceutical preparations
WITNESSETH:Manufacturing & Distribution Agreement • August 29th, 2001 • Sicor Inc • Pharmaceutical preparations • New York
EXHIBIT 10.9 ------------ DISTRIBUTION AGREEMENT ---------------------- BetweenDistribution Agreement • May 15th, 1997 • Gensia Sicor Inc • Pharmaceutical preparations
EXHIBIT 10.1 [GRAPHIC OMITTED] SILICON VALLEY FINANCIAL SERVICES A Division of Silicon Valley Bank 3003 Tasman Drive Santa Clara, Ca. 95054 (408) 654-1000 - Fax (408) 980-6410 FACTORING AGREEMENT This Factoring Agreement (the "Agreement") is made on...Factoring Agreement • November 14th, 1997 • Gensia Sicor Inc • Pharmaceutical preparations • California
GENSIA SICOR INC. 2.675% Subordinated Convertible Notes due May 1, 2004Subordinated Convertible Note • August 14th, 1997 • Gensia Sicor Inc • Pharmaceutical preparations
GENSIA SICOR INC. (the "Company"), a Delaware corporation, for value received, hereby promises to pay to [HEALTH CARE CAPITAL PARTNERS, L.P.], or registered assigns, the principal amount of TWENTY MILLION AND 00/100 DOLLARS [$20,000,000.00] on May 1, 2004, with interest (computed on the basis of a 360- day year of twelve 30-day months) on the unpaid balance of such principal amount at the rate of 2.675% per annum from the date hereof, payable quarterly, in arrears, on the last business day of March, June, September and December, until such unpaid balance shall become due and payable (whether at maturity or at a date fixed for redemption or by declaration or otherwise). During the continuance of any Default or Event of Default, the Company shall pay interest on the outstanding principal of, and any other amounts (other than interest), if any, due on the Notes and (to the extent legally enforceable) on any overdue installment of interest, at the rate of 11.75% per annum (computed on the
ContractStockholders Agreement • October 31st, 2003 • Sicor Inc • Pharmaceutical preparations • Delaware
STOCKHOLDERS AGREEMENT, dated as of October 31, 2003 (this “Agreement”), between Teva Pharmaceutical Industries Limited, an Israeli corporation (“Parent”), and the parties listed on Schedule A attached hereto (the “Stockholders”).
EXHIBIT 10.3 ------------ [CERTAIN INFORMATION HAS BEEN OMITTED HEREIN PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT UNDER RULE 24b-2. THE REDACTED MATERIAL HAS BEEN SEPARATELY FILED WITH THE COMMISSION.] DISTRIBUTION AND SUPPLY AGREEMENT This...Distribution and Supply Agreement • May 15th, 1997 • Gensia Sicor Inc • Pharmaceutical preparations
